Highmark Medicare Advantage Medical Policy in West Virginia

Section: Miscellaneous
Number: Z-56
Topic: Trigger Point, Tendon Sheath Injections
Effective Date: June 18, 2011
Issued Date: April 9, 2012

General Policy

Trigger points are hyperirritable areas located in skeletal muscle. They produce pain locally and often accompany chronic musculoskeletal disorders. Trigger point injections are an effective treatment modality used to inactivate trigger points and provide prompt relief of symptoms.

Indications and Limitations of Coverage

Coverage is allowed for tendon sheath, ligament, or trigger point injections which are medically necessary based on specific symptoms, illness or injuries. Such injections will be covered when all of the following are present:

  1. The patient’s clinical condition is marked by substantial pain and/or significant functional disability.
  2. Other conservative therapy has not provided acceptable relief, is contraindicated, or not appropriate.
  3. There is a reasonable likelihood that injection will significantly improve the patient’s pain and/or functional disability.

Services reported for conditions not addressed on this policy will be denied as not medically necessary.  A provider cannot bill the member for the denied service unless the provider has given advance written notice, informing the member that the service may be deemed not medically necessary and providing an estimate of the cost. The member must agree in writing to assume financial responsibility, in advance of receiving the service. The signed agreement, in the form of a Pre-Service Denial Notice, should be maintained in the provider's records.

Limitations

Trigger point injections used on a routine basis for patients with chronic non-malignant pain syndromes are not medically necessary and are not covered.

Only injections of local anesthetics, corticosteroids, and collagenase clostridium histolyticum for Dupuytren's contracture with a palpable cord are covered. Injections consisting of only saline and/or botanical substances are not supported in the peer-reviewed literature and are not covered.

Services performed for excessive frequency are not medically necessary. Frequency is considered excessive when services are performed more frequently than generally accepted by peers and the reason for additional services is not justified by documentation.

Tenosynovitis treatments should be of short duration (1-2 injections). Documentation in the medical record must support the medical necessity for additional injections.

Repeat trigger point injections may be necessary when there is evidence of persistent pain or inflammation. Generally more than three injections of the same trigger point are not indicated. Evidence of partial improvements to the range of motion in any muscle area after an injection would justify a repeat injection. The medical record must clearly reflect the medical necessity for repeated injections.

Documentation Requirements

The patient's medical record must document the medical necessity of services performed for each date of service submitted on a claim, and documentation must be available on request.

Documentation must be available in the patient’s medical record to support the medical necessity of frequent or prolonged injection regimens.

NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

2052620550205512055220553 

Coding Guidelines

The following coding guidelines from Article A34409 were removed as of 06/18/2011.

The following coding guidelines must be used in conjunction with the Trigger Point, Tendon Sheath Injections LCD:

Publications

References

Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.

Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.

Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

www.cms.gov
www.medicare.gov

Attachments

Procedure Code Attachments

Diagnosis Codes

Use of these codes does not guarantee reimbursement. The patient's medical record must document that the coverage criteria in this policy have been met.

Code 20526

354.0    

Codes 20550 and 20551

354.1-355.6 710.0 714.0 714.30-714.33
714.4 714.9 720.0-720.2720.81-720.89
723.1 724.1-724.5 726.0726.10-726.19
726.2726.30-726.39726.4-726.5726.60-726.69
726.70-726.79726.8726.90-726.91 727.00-727.06
727.42 727.43 727.49 727.51
727.83 728.6728.71-728.79729.0
733.6    

Codes 20552 and 20553

723.1724.1724.3724.5
728.85729.0729.1729.4
729.5784.0  

Glossary





This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Medicare Advantage plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Medicare Advantage retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Medicare Advantage. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.